Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...

Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds ...

KKR plans to announce a deal that includes increasing its stake to 12% with the option to buy up to an additional 2.9% in the future, WSJ reported. Henry Schein has agreed to give the private equity ...

As a result, KKR will become the largest non-index fund shareholder in the Company with a 12% position, demonstrating the firm’s confidence in Henry Schein, its management team, and its BOLD+1 ...

KKR to invest $250M in Henry Schein, increasing stake to 12%, with an option to reach 14.9%. Henry Schein raises share buyback program by $500M and expects moderate revenue and EPS growth in 2025.

Henry Schein (NASDAQ:HSIC) announced Wednesday a strategic investment from funds affiliated with private equity firm KKR (NYSE:KKR) and released its preliminary Q4 2024 financials and full-year ...

Henry Schein (HSIC) announced a strategic investment by funds affiliated with KKR,(KKR) a global investment firm.In addition to KKR’s current ...

Henry Schein and KKR will collaborate on a range of value-creation opportunities. Henry Schein will issue new shares of common stock to funds affiliated with KKR for a $250 million investment ...

In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...

KKR has made an investment in Henry Schein Inc, a Melville, New York-based provider of healthcare solutions to office-based dental and medical practitioners. Stanley Bergman serves as CEO of Henry ...